The blind leading the blind: Use and misuse of blinding in randomized controlled trials

Contemporary Clinical Trials

Volumn 32, Issue 2, 2011, Pages 240-243

  Miller, Larry E ^a   Stewart, Morgan E ^a  

^a Research and Clinical Services   (United States)

Author keywords

Bias; Blinding; Double blind; Masking; Randomized controlled trial; Single blind; Triple blind

Indexed keywords

ARTICLE; CONCEPT ANALYSIS; DOUBLE BLIND PROCEDURE; NOMENCLATURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE BLIND PROCEDURE; STANDARDIZATION; TRIPLE BLIND PROCEDURE;

DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SINGLE-BLIND METHOD; TERMINOLOGY AS TOPIC;

EID: 79551561460     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2010.11.004     Document Type: Article

References (27)

1. Schulz K.F., Chalmers I., Altman D.G. The landscape and lexicon of blinding in randomized trials. Ann Intern Med 2002, 136:254-259.
2. Spanos N.P., Burgess C.A., Cross P.A., MacLeod G. Hypnosis, reporting bias, and suggested negative hallucinations. J Abnorm Psychol 1992, 101:192-199.
3. Schulz K.F., Chalmers I., Hayes R.J., Altman D.G. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273:408-412.
4. Benson H., McCallie D.P. Angina pectoris and the placebo effect. N Engl J Med 1979, 300:1424-1429.
5. Lijmer J.G., Mol B.W., Heisterkamp S., Bonsel G.J., Prins M.H., van der Meulen J.H., et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999, 282:1061-1066.
6. Kaptchuk T.J. The double-blind, randomized, placebo-controlled trial: Gold standard or golden calf?. J Clin Epidemiol 2001, 54:541-549.
7. Devereaux P.J., Manns B.J., Ghali W.A., Quan H., Lacchetti C., Montori V.M., et al. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA 2001, 285:2000-2003.
8. Montori V.M., Bhandari M., Devereaux P.J., Manns B.J., Ghali W.A., Guyatt G.H. In the dark: the reporting of blinding status in randomized controlled trials. J Clin Epidemiol 2002, 55:787-790.
9. Schulz K.F., Altman D.G., Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c332.
10. Moher D., Hopewell S., Schulz K.F., Montori V., Gotzsche P.C., Devereaux P.J., et al. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c869.
11. Miller F.G. Sham surgery: An ethical analysis. Sci Eng Ethics 2004, 10:157-166.
12. Mehta S., Myers T.G., Lonner J.H., Huffman G.R., Sennett B.J. The ethics of sham surgery in clinical orthopaedic research. J Bone Joint Surg Am 2007, 89:1650-1653.
13. Gotzsche P.C. Blinding during data analysis and writing of manuscripts. Control Clin Trials 1996, 17:285-293.
14. Fergusson D., Glass K.C., Waring D., Shapiro S. Turning a blind eye: The success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ 2004, 328:432.
15. Chow S.C., Shao J. Analysis of clinical data with breached blindness. Stat Med 2004, 23:1185-1193.
16. Altman D.G., Schulz K.F., Moher D. Turning a blind eye: Testing the success of blinding and the CONSORT statement. BMJ 2004, 328:1135. author reply 6.
17. Schulz K.F., Altman D.G., Moher D. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. Trials 2010, 11:32.
18. Kolahi J., Bang H., Park J. Towards a proposal for assessment of blinding success in clinical trials: Up-to-date review. Community Dent Oral Epidemiol 2009, 37:477-484.
19. Henneicke-von Zepelin H.H. Assessment of blinding in clinical trials. Contemp Clin Trials 2005, 26:512. author reply 4-5.
20. Hemila H. Assessment of blinding may be inappropriate after the trial. Contemp Clin Trials 2005, 26:512-514. Author reply 4-5.
21. Senn S.J. Turning a blind eye: Authors have blinkered view of blinding. BMJ 2004, 328:1135-1136. author reply 6.
22. Sackett D.L. Turning a blind eye: Why we don't test for blindness at the end of our trials. BMJ 2004, 328:1136.
23. Bang H., Ni L., Davis C.E. Assessment of blinding in clinical trials. Control Clin Trials 2004, 25:143-156.
24. Sackett D.L. Commentary-Measuring the success of blinding in RCTs: Don't, must, can't or needn't?. Int J Epidemiol 2007, 36:664-665.
25. Hrobjartsson A., Forfang E., Haahr M.T., Als-Nielsen B., Brorson S. Blinded trials taken to the test: An analysis of randomized clinical trials that report tests for the success of blinding. Int J Epidemiol 2007, 36:654-663.
26. Kaptchuk T.J. Intentional ignorance: A history of blind assessment and placebo controls in medicine. Bull Hist Med 1998, 72:389-433.
27. International Conference on Harmonisation Structure and content of clinical study reports 1995, E3.